It has been
very long since I blogged. At MABIC we were really preoccupied with many
assignments; one of it is our newspaper, The Petri Dish. What made
me to activate our blog was the feedback we received everywhere we went. It
made us realise that we had followers and that our write ups were appreciated.
I take this opportunity to thank all our readers.
I am
dedicating this post to the recently concluded Meetings of the Parties to
Cartagena Protocol on Biosafety (MOP6). This meeting is held once every two
years and this year was hosted by the Government of India in Hyderabad. MOPs
discuss how GMOs/LMOs should be regulated.
Cartagena
Protocol on Biosafety (CPB) has 164 countries (Parties) that have ratified this
protocol. A little tamer compared to previous MOPs as the contentious agenda
items have all been deliberated and negotiated before. However, Risk Assessment
and Risk Management (RA/RM) and Socioeconomic Considerations (SEC) took the
limelight.
At the side
event organised by PRRI/ISAAA/IFPRI/ICRISAT at MOP6 as a speaker
What is
interesting about SEC is that only negative impacts were discussed even though
there are documented positive impacts of GM crops to farmers and countries that
have adopted GM crops. Poverty alleviation and reduced exposure to pesticides
were hardly presented by countries that oppose GM crops. But they never fail to
present imaginary negative impacts.
Another
important agenda item is Article 35 of CPB that calls for assessment and review of the effectiveness of the
functioning of the CPB. In my opinion, this should be the most important agenda
as Parties should seriously evaluate the effectiveness of all the instruments
that have been established in the past 10 years since CPB came into force. One
white elephant is the Biosafety Clearing House (BCH) that is hardly updated by
Parties.
After attending three MOPs,
I feel MOPs promote another type of tourism – Biotourism. The amount of money
spent for these meetings are astronomical not to mention the associated
meetings that take place in between MOPs.
Is all this fanfare
necessary for a technology that has been around for 16 years without single
health or environmental hazard? GM foods have undergone the biggest “clinical
trial” with billions consuming it everyday.
By
Mahaletchumy Arujanan